4TL-75351-37129
4 vaccinations
6 coded responses
44 check-ins
5 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 972 / OR
- Registered
- 2021-03-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-17
Registered in v-safe
-
2021-03-17
Dose 1 — Moderna
- 2021-03-17
- 2021-03-19
- 2021-03-20
- 2021-03-21
- 2021-03-22
-
2021-03-23
Survey response — days 1–6 daily, dose 1MedDRA: Urinary tract infection — Feeling: Good · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Urinary tract infectionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-23
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-03-24
-
2021-03-31
Survey response — day 14, dose 1MedDRA: Bacterial vaginosis — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Bacterial vaginosisMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-31
Report sent to call center — day 14, dose 1Get care from a doctor or other healthcare professional1 call case(s)
- 2021-04-07
-
2021-04-14
Dose 2 — Moderna
-
2021-04-14
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to workAdult check-in
-
2021-04-15
Survey response — days 1–6 daily, dose 2MedDRA: Insomnia — Feeling: Poor · Site: Pain, Redness · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesFree text: InsomniaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-16
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-04-18
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-04-19
- 2021-04-20
- 2021-04-21
- 2021-04-28
- 2021-05-05
- 2021-05-12
- 2021-05-19
- 2021-05-26
- 2021-07-14
- 2021-10-13
-
2021-10-27
Dose 3 — Moderna
- 2021-10-27
-
2021-10-28
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain, Redness · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-10-29
Survey response — days 1–6 daily, dose 3MedDRA: Acne, Skin lesion — Feeling: Fair · Site: Pain, Redness, Swelling · Joint pains, DiarrheaFree text: Acne lesionMedDRA releases: 2024-11 · check-in free text available
-
2021-10-30
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness · Muscle or body achesAdult check-in
- 2021-10-31
-
2021-11-01
Survey response — days 1–6 daily, dose 3MedDRA: Oropharyngeal pain — Feeling: GoodFree text: Sore throatMedDRA releases: 2024-11 · check-in free text available
- 2021-11-02
- 2021-11-03
- 2021-11-10
- 2021-11-17
- 2021-11-24
- 2021-12-01
- 2021-12-08
- 2022-01-25
- 2022-01-26
- 2022-04-27
-
2022-09-26
Dose 4 — Other-UnknownCo-administered: Flu
- 2022-10-27
- 2022-10-27
- 2022-10-31
- 2022-11-07
- 2022-12-26
-
2023-03-27
Survey response — 6 months, dose 4MedDRA: Fatigue, Rhinorrhoea — Feeling: Good · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-17 | Moderna | |
| 2 | 2021-04-14 | Moderna | |
| 3 | 2021-10-27 | Moderna | No |
| 4 | 2022-09-26 | Other-Unknown | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-03-23 | Unsuccessful | |
| 2021-03-31 | Unsuccessful |
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Urinary tract infection
Release 6 — day 14, dose 1
Symptoms: Bacterial vaginosis
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Insomnia
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Acne lesion
Systemic reaction (other): Sore throat
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Bacterial vaginosis | ✓ | ✓ | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Acne | · | · | ✓ |
| SRO | Insomnia | ✓ | ✓ | ✓ |
| SRO | Oropharyngeal pain | · | · | ✓ |
| SRO | Skin lesion | · | · | ✓ |
| SRO | Urinary tract infection | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release